drugset / Trial / NCT00766870

Efficacy and Safety of Lu AA34893 in Patients With Major Depressive Disorder

NCT00766870

Phase 2 Terminated 35 enrolled H. Lundbeck A/S
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to evaluate the efficacy, safety and tolerability of three fixed dosages of Lu AA34893 compared to placebo in the treatment of patients with Major Depressive Disorder.

Timeline

Start
2008-09
Primary completion
2009-01
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Lu AA34893 Unknown Oral
Subject Venlafaxine Extended Release Unknown Oral